AMY ABERNETHY was named chair of a new CancerLinQ advisory committee within the Institute for Quality, an affiliate of the American Society of Clinical Oncology.
Issue 44 – Nov. 22, 2013 PDF ASCO Vying for Big Role in Big Data Conversation with The Cancer Letter: ASCO President Clifford HudisThe American Society of Clinical Oncology is in the final stages of developing a request for proposals for its CancerLinQ system. The RFP is expected to be issued early in 2014. Biospecimen […]
NCI NewsVarmus: "We Are Shrinking Everything"To Keep Grant Numbers Level During CutsVarmus's Remarks to the BSA, Nov. 7, 2013 from The Cancer Letter on Vimeo.
ISSUE 43 - NOV. 15, 2013PDF"Master Protocol" To Rely on Biomarkers In Testing Multiple Lung Cancer AgentsA new kind of clinical trial that will assign patients to therapy based on molecular characteristics of their disease is being launched by a coalition of government agencies, pharmaceutical companies, and a non-government organization.
In BriefLYNNE PENBERTHY was named associate director for surveillance research in NCI's Division of Cancer Control and Population Sciences.
